| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| HLA-E*0103 & B2M | Unconjugated Human HLA-E*01:03 & B2M Monomer Protein (Peptide free, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug | |||
| HLA-E*0103 & B2M | Biotinylated Human HLA-E*01:03&B2M Monomer Protein (Peptide free, MALS verified) | Human | HEK293 | MALSSDS-PAGE | $125.00 25ug | |||
| HLA-E*0103 & B2M | PE-Labeled Human HLA-E*01:03&B2M Tetramer Protein (Peptide free) | Human | HEK293 | $410.00 25ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Aldafermin | NGM-282; M70; M-70; NGM282 | Phase 2 Clinical | Ngm Biopharmaceuticals Inc | Liver Cirrhosis, Biliary; Constipation; Irritable Bowel Syndrome; Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency; Bile acid malabsorption (BAM); Fibrosis; Cholangitis, Sclerosing; Diarrhea; Hepatic Insufficiency; Malabsorption Syndromes; Diabetes Mellitus | 상세 |
